Roy Eldor

3.8k total citations · 1 hit paper
70 papers, 2.9k citations indexed

About

Roy Eldor is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Roy Eldor has authored 70 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Endocrinology, Diabetes and Metabolism, 24 papers in Surgery and 19 papers in Molecular Biology. Recurrent topics in Roy Eldor's work include Diabetes Management and Research (33 papers), Diabetes Treatment and Management (25 papers) and Pancreatic function and diabetes (20 papers). Roy Eldor is often cited by papers focused on Diabetes Management and Research (33 papers), Diabetes Treatment and Management (25 papers) and Pancreatic function and diabetes (20 papers). Roy Eldor collaborates with scholars based in Israel, United States and United Kingdom. Roy Eldor's co-authors include Muhammad Abdul‐Ghani, Ralph A. DeFronzo, Itamar Raz, Giuseppe Daniele, Aurora Merovci, Devjit Tripathy, Juan Xiong, Luke Norton, Carolina Solis‐Herrera and Teresa Vanessa Fiorentino and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and PLoS ONE.

In The Last Decade

Roy Eldor

67 papers receiving 2.8k citations

Hit Papers

Dapagliflozin improves muscle insulin sensitivity but enh... 2014 2026 2018 2022 2014 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Dapagliflozin improves muscle insulin sensitivity but enhances endogenous glucose production
    2014 635 citations Roy Eldor, Luke Norton et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roy Eldor Israel 24 1.8k 1.1k 1.1k 405 391 70 2.9k
Steven C. Griffen United States 28 1.8k 1.0× 1.1k 1.0× 888 0.8× 707 1.7× 427 1.1× 42 3.0k
Shimpei Fujimoto Japan 30 842 0.5× 896 0.8× 1.0k 1.0× 332 0.8× 399 1.0× 99 2.5k
Curtis Triplitt United States 30 1.8k 1.0× 834 0.7× 1.1k 1.0× 527 1.3× 187 0.5× 89 2.7k
Monika Kellerer Germany 32 1.2k 0.7× 838 0.7× 1.6k 1.5× 922 2.3× 311 0.8× 126 3.5k
Agata Maria Rabuazzo Italy 30 1.3k 0.8× 1.2k 1.0× 911 0.8× 595 1.5× 315 0.8× 91 3.0k
Andrej Janež Slovenia 35 2.3k 1.3× 869 0.8× 1.1k 1.1× 564 1.4× 255 0.7× 179 4.4k
Marcus Hompesch United States 27 1.6k 0.9× 966 0.9× 627 0.6× 223 0.6× 227 0.6× 82 2.3k
Luke Norton United States 26 2.3k 1.3× 1.4k 1.2× 1.6k 1.5× 598 1.5× 232 0.6× 54 3.4k
Teresa Vanessa Fiorentino Italy 28 1.7k 1.0× 750 0.7× 1.1k 1.0× 681 1.7× 201 0.5× 109 3.3k
George Dailey United States 30 2.9k 1.6× 1.3k 1.1× 1.2k 1.1× 674 1.7× 833 2.1× 72 4.2k

Countries citing papers authored by Roy Eldor

Since Specialization
Citations

This map shows the geographic impact of Roy Eldor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roy Eldor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roy Eldor more than expected).

Fields of papers citing papers by Roy Eldor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roy Eldor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roy Eldor. The network helps show where Roy Eldor may publish in the future.

Co-authorship network of co-authors of Roy Eldor

This figure shows the co-authorship network connecting the top 25 collaborators of Roy Eldor. A scholar is included among the top collaborators of Roy Eldor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roy Eldor. Roy Eldor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Dicker, Dror, et al.. (2023). Subcutaneous Semaglutide Use for Weight Management: Practice and Attitudes of Physicians in Israel.. PubMed. 25(10). 664–668. 3 indexed citations
3.
Brzezinski, Rafael Y., Shlomo Berliner, David Zeltser, et al.. (2023). Transitioning from having no metabolic abnormality nor obesity to metabolic impairment in a cohort of apparently healthy adults. Cardiovascular Diabetology. 22(1). 226–226. 2 indexed citations
4.
5.
Buch, Assaf, Arie Ben‐Yehuda, Vanessa Rouach, et al.. (2022). Validation of a multi-frequency bioelectrical impedance analysis device for the assessment of body composition in older adults with type 2 diabetes. Nutrition and Diabetes. 12(1). 45–45. 21 indexed citations
6.
7.
Eldor, Roy, Eugene Merzon, Orly Tamir, et al.. (2021). Effect of a primary-care-team focused diabetes educational program project on diabetes care quality indicators in a large health maintenance organization. Diabetes Research and Clinical Practice. 177. 108896–108896. 3 indexed citations
8.
Marcus, Yonit, Roy Eldor, Mariana Yaron, et al.. (2020). Improving blood glucose level predictability using machine learning. Diabetes/Metabolism Research and Reviews. 36(8). e3348–e3348. 22 indexed citations
9.
Hollander, Priscilla, Raymond L. H. Lam, Gregory T. Golm, et al.. (2018). Efficacy and safety of MK‐1293 insulin glargine compared with originator insulin glargine (Lantus) in type 2 diabetes: A randomized, open‐label clinical trial. Diabetes Obesity and Metabolism. 20(9). 2229–2237. 10 indexed citations
10.
Home, Philip, Raymond L. H. Lam, Gregory T. Golm, et al.. (2018). Efficacy and safety of MK‐1293 insulin glargine compared with originator insulin glargine (Lantus) in type 1 diabetes: A randomized, open‐label clinical trial. Diabetes Obesity and Metabolism. 20(9). 2220–2228. 5 indexed citations
11.
12.
Eldor, Roy, et al.. (2013). Glucose-Reducing Effect of the ORMD-0801 Oral Insulin Preparation in Patients with Uncontrolled Type 1 Diabetes: A Pilot Study. PLoS ONE. 8(4). e59524–e59524. 75 indexed citations
13.
Livshits, Leonid, Itamar Raz, Avivit Cahn, et al.. (2012). Effect of Short-Term Hyperglycemia on Protein Kinase C Alpha Activation in Human Erythrocytes. The Review of Diabetic Studies. 9(2-3). 94–103. 14 indexed citations
14.
Eldor, Roy, Benjamin Gläser, Merav Fraenkel, et al.. (2011). Glucagonoma and the glucagonoma syndrome - cumulative experience with an elusive endocrine tumour. Clinical Endocrinology. 74(5). 593–598. 74 indexed citations
15.
Schroeder, Josh E., et al.. (2011). Benefits of a simple glycaemic protocol in an orthopaedic surgery ward: a randomized prospective study. Diabetes/Metabolism Research and Reviews. 28(1). 71–75. 26 indexed citations
16.
Eldor, Roy, Miriam Kidron, & Ehud Arbit. (2009). Open‐label study to assess the safety and pharmacodynamics of five oral insulin formulations in healthy subjects. Diabetes Obesity and Metabolism. 12(3). 219–223. 29 indexed citations
17.
Eldor, Roy, Sameer Kassem, & Itamar Raz. (2009). Immune modulation in type 1 diabetes mellitus using DiaPep277: a short review and update of recent clinical trial results. Diabetes/Metabolism Research and Reviews. 25(4). 316–320. 20 indexed citations
18.
Raz, Itamar, Roy Eldor, & Yaakov Naparstek. (2005). Immune modulation for prevention of type 1 diabetes mellitus. Trends in biotechnology. 23(3). 128–134. 36 indexed citations
19.
Eldor, Roy, et al.. (2005). Early use of insulin in type 2 diabetes. Diabetes Research and Clinical Practice. 68. S30–S35. 10 indexed citations
20.
Raz, Itamar, Roy Eldor, Simona Cernea, & Eleazar Shafrir. (2004). Diabetes: insulin resistance and derangements in lipid metabolism. Cure through intervention in fat transport and storage. Diabetes/Metabolism Research and Reviews. 21(1). 3–14. 166 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Steven C. Griffen Breakdown of academic impact, for papers by Shimpei Fujimoto Breakdown of academic impact, for papers by Curtis Triplitt Breakdown of academic impact, for papers by Monika Kellerer Breakdown of academic impact, for papers by Agata Maria Rabuazzo Breakdown of academic impact, for papers by Andrej Janež Breakdown of academic impact, for papers by Marcus Hompesch Breakdown of academic impact, for papers by Luke Norton Breakdown of academic impact, for papers by Teresa Vanessa Fiorentino Breakdown of academic impact, for papers by George Dailey
Rankless by CCL
2026